These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Delaware
|
04-2985631
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
x
|
|
|
|
|
|
|
(Do not check if a smaller reporting company)
|
|||
|
|
|
|
|
|
Class
|
Outstanding at February 10, 2012
|
|
Common stock, par value $.10
|
3,470,322
|
|
PAGE
|
|
|
2
|
|
|
2
|
|
|
2
|
|
|
3
|
|
|
3
|
|
|
4
|
|
|
5
|
|
|
12
|
|
|
14
|
|
|
15
|
|
|
15
|
|
|
15
|
|
|
15
|
|
|
17
|
|
|
17
|
|
|
17
|
|
|
17
|
|
|
17
|
|
|
18
|
|
|
18
|
|
|
(in thousands of dollars except per share data)
|
||||||||||
|
December 31, 2011
(unaudited)
|
September 30, 2011
(derived from audited statements)
|
|||||||||
|
ASSETS
|
||||||||||
|
Current assets:
|
||||||||||
|
Cash and cash equivalents
|
$ | 306 | $ | 1,797 | ||||||
|
Trade receivables, net of allowances for doubtful accounts of $53
at December 31, 2011 and $49 at September 30, 2011
|
6,264 | 5,315 | ||||||||
|
Other receivables
|
519 | 637 | ||||||||
|
Inventories
|
7,794 | 7,478 | ||||||||
|
Prepaid expenses and other current assets
|
1,147 | 1,281 | ||||||||
|
Total current assets
|
16,030 | 16,508 | ||||||||
|
Property, plant and equipment:
|
||||||||||
|
At cost
|
10,718 | 10,648 | ||||||||
|
Less: accumulated depreciation and amortization
|
(8,526 | ) | (8,401 | ) | ||||||
|
Net property, plant and equipment
|
2,192 | 2,247 | ||||||||
|
Long-term deferred tax assets
|
2,708 | 2,699 | ||||||||
|
Goodwill
|
1,435 | 1,435 | ||||||||
|
Other-long term assets
|
59 | 58 | ||||||||
|
Total assets
|
$ | 22,424 | $ | 22,947 | ||||||
|
LIABILITIES AND STOCKHOLDERS’ INVESTMENT
|
||||||||||
|
Current liabilities:
|
||||||||||
|
Current portion of long term debt
|
$ | 39 | $ | 39 | ||||||
|
Accounts payable
|
3,554 | 3,800 | ||||||||
|
Accrued expenses
|
1,586 | 2,106 | ||||||||
|
Accrued and deferred taxes on income
|
61 | 65 | ||||||||
|
Total current liabilities
|
5,240 | 6,010 | ||||||||
|
Liability for pension benefits
|
7,593 | 7,634 | ||||||||
|
Long term debt
|
1,802 | 1,813 | ||||||||
|
Total liabilities
|
14,635 | 15,457 | ||||||||
|
S
tockholders’ equity:
|
||||||||||
|
Preferred stock, par value $.10 per share - authorized - 1,000,000 shares;
outstanding – none
|
- | - | ||||||||
|
Common stock, par value $.10 per share - authorized - 8,000,000 shares;
Outstanding 3,470,322 shares at December 31, 2011 and 3,360,322 shares at
September 30, 2011
|
347 | 336 | ||||||||
|
Premium paid in on common stock
|
5,345 | 5,295 | ||||||||
|
Retained earnings
|
8,751 | 8,467 | ||||||||
|
Accumulated other comprehensive loss
|
(6,654 | ) | (6,608 | ) | ||||||
|
Total stockholders’ equity
|
7,789 | 7,490 | ||||||||
|
Total liabilities and stockholders’ equity
|
$ | 22,424 | $ | 22,947 | ||||||
|
(in thousands of dollars except per share data)
|
||||||||||
|
Three months ended
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Net sales
|
$ | 8,515 | $ | 6,883 | ||||||
|
Cost of sales
|
(5,533 | ) | (4,515 | ) | ||||||
|
Gross profit
|
2,982 | 2,368 | ||||||||
|
Selling, research and administrative expenses
|
(2,730 | ) | (2,335 | ) | ||||||
|
Operating income
|
252 | 33 | ||||||||
|
Interest expense
|
(56 | ) | (31 | ) | ||||||
|
Interest income
|
23 | - | ||||||||
|
Foreign currency gain
|
154 | 4 | ||||||||
|
Income before income tax
|
373 | 6 | ||||||||
|
Income tax provision
|
(89 | ) | (1 | ) | ||||||
|
Net income
|
$ | 284 | $ | 5 | ||||||
|
Basic income per share
|
$ | . .09 | $ | .00 | ||||||
|
Fully diluted income per share
|
$ | .08 | $ | .00 | ||||||
|
(in thousands of dollars)
|
||||||||||
|
Three months ended
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Net income
|
$ | 284 | $ | 5 | ||||||
|
Foreign currency translation adjustment
|
(92 | ) | (53 | ) | ||||||
|
Amortization of pension transition items to income
|
46 | 58 | ||||||||
|
Comprehensive income
|
$ | 238 | $ | 10 | ||||||
|
(in thousands of dollars)
|
||||||||||
|
Three months ended
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Cash flow from operating activities:
|
||||||||||
|
Net income
|
$ | 284 | $ | 5 | ||||||
|
Adjustments to reconcile net income to net cash (used by) generated from operating activities:
|
||||||||||
|
Depreciation
|
156 | 146 | ||||||||
|
Stock-based compensation
|
60 | 36 | ||||||||
|
Pension contributions less than pension expense
|
38 | 82 | ||||||||
|
Deferred tax provision
|
113 | 5 | ||||||||
|
Increase (decrease) in cash resulting from changes in operating assets and
liabilities:
|
||||||||||
|
Trade and other receivables
|
(907 | ) | (105 | ) | ||||||
|
Inventories
|
(336 | ) | (887 | ) | ||||||
|
Prepaid expenses and other current assets
|
(8 | ) | 146 | |||||||
|
Accounts payable
|
(246 | ) | 733 | |||||||
|
Accrued expenses
|
(503 | ) | 88 | |||||||
|
Accrued and deferred taxes on income
|
(6 | ) | (55 | ) | ||||||
|
Net cash (used by) generated from operating activities
|
(1,355 | ) | 194 | |||||||
|
Cash flow used by investing activities:
|
||||||||||
|
Acquisition of property, plant and equipment
|
(104 | ) | (300 | ) | ||||||
|
Net cash used by investing activities
|
(104 | ) | (300 | ) | ||||||
|
Cash flow used by financing activities:
|
||||||||||
|
Repayments of long term debt
|
(10 | ) | (9 | ) | ||||||
|
Net cash used by financing activities
|
(10 | ) | (9 | ) | ||||||
|
Effect of exchange rate changes on cash
|
(22 | ) | (33 | ) | ||||||
|
Net decrease in cash
|
(1,491 | ) | (148 | ) | ||||||
|
Beginning balance - cash and cash equivalents
|
1,797 | 803 | ||||||||
|
Ending balance - cash and cash equivalents
|
$ | 306 | $ | 655 | ||||||
|
Supplemental disclosure of cash flow information:
|
||||||||||
|
Cash paid for income taxes
|
12 | - | ||||||||
|
Cash paid for interest
|
$ | 56 | $ | 31 | ||||||
|
(1)
|
Basis of presentation
|
|
Shares
under
Option
|
Weighted average
Exercise
Price
|
Weighted average
remaining contractual life
(years)
|
Aggregate
Intrinsic
Value
|
|||||||||||||||
|
Outstanding at September 30, 2011
|
46,000 | $ | 5.62 |
1 year
|
$ | 65,500 | ||||||||||||
|
Granted
|
- | - | - | - | ||||||||||||||
|
Exercised
|
- | - | - | - | ||||||||||||||
|
Cancelled
|
(10,000 | ) | 9.60 | - | - | |||||||||||||
|
Outstanding at December 31, 2011
|
36,000 | $ | 4.51 |
1 year
|
$ | 9,700 | ||||||||||||
|
Exercisable at December 31, 2011
|
31,000 | $ | 4.50 |
1 year
|
$ | 8,400 | ||||||||||||
|
Exercisable and expected to vest at December 31, 2011
|
31,000 | $ | 4.50 |
1 year
|
$ | 8,400 | ||||||||||||
|
Number of shares of Restricted Stock
|
Weighted Average Grant-Date Fair Value
|
|||||||||
|
Non-vested balance as of September 30, 2011
|
50,000 | $ | 5.21 | |||||||
|
Granted
|
110,000 | $ | 5.75 | |||||||
|
Vested
|
(11,000 | ) | $ | 4.09 | ||||||
|
Forfeited
|
- | $ | - | |||||||
|
Non-vested balance as of December 31, 2011
|
149,000 | $ | 5.69 | |||||||
|
(in thousands except per share data)
|
||||||||||
|
Three Months ended
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Net income
|
$ | 284 | $ | 5 | ||||||
|
Weighted average shares outstanding - basic
|
3,313 | 3,285 | ||||||||
|
Basic income per share
|
$ | .09 | $ | .00 | ||||||
|
Common stock equivalents
|
49 | 45 | ||||||||
|
Weighted average shares outstanding - diluted
|
3,362 | 3,330 | ||||||||
|
Diluted income per share
|
$ | .08 | $ | .00 | ||||||
|
No. of options that are anti-dilutive excluded from calculation of common stock equivalents
|
- | 10 | ||||||||
|
(in thousands of dollars)
|
||||||||||||||||
|
Three months ended December 31, 2011
|
||||||||||||||||
|
Controls
|
Capacitors
|
Corporate
|
Total
|
|||||||||||||
|
Sales to external customers
|
8,073 | 442 | - | 8,515 | ||||||||||||
|
Inter
-
segment revenues
|
- | 5 | - | 5 | ||||||||||||
|
Operating income (loss)
|
296 | (28 | ) | (16 | ) | 252 | ||||||||||
|
Identifiable assets
|
21,118 | 1,147 | 159 | 22,424 | ||||||||||||
|
Three months ended January 1, 2011
|
||||||||||||||||
|
Controls
|
Capacitors
|
Corporate
|
Total
|
|||||||||||||
|
Sales to external customers
|
6,386 | 497 | - | 6,883 | ||||||||||||
|
Inter-segment revenues
|
- | 3 | - | 3 | ||||||||||||
|
Operating income (loss)
|
3 | 57 | (27 | ) | 33 | |||||||||||
|
Identifiable assets
|
19,401 | 982 | 151 | 20,534 | ||||||||||||
|
(in thousands of dollars)
|
||||||||
|
Three Months ended
|
||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||
|
Electronic controls for zero emission and hybrid electric vehicles
|
$ | 5,584 | $ | 3,701 | ||||
|
Accessory and aftermarket products and services
|
2,489 | 2,685 | ||||||
|
Total electronic controls segment revenues
|
$ | 8,073 | $ | 6,386 | ||||
|
(in thousands of dollars)
|
||||||||||
|
Three Months ended
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Research and development expense
|
$ | 817 | $ | 696 | ||||||
|
Percentage of sales
|
9.6 | 10.1 | ||||||||
|
(in thousands of dollars)
|
||||||||||
|
Three Months ended
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Service cost
|
$ | 66 | $ | 110 | ||||||
|
Interest cost
|
312 | 317 | ||||||||
|
Expected return on plan assets
|
(279 | ) | (273 | ) | ||||||
|
Amortization of net loss
|
67 | 68 | ||||||||
|
Amortization of prior service cost
|
(6 | ) | 12 | |||||||
|
Net periodic benefit cost
|
160 | 234 | ||||||||
|
Net cost of defined contribution plans
|
$ | 39 | $ | 7 | ||||||
|
(in thousands of dollars)
|
||||||||||
|
Three Months ended
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Liability for pension benefits at beginning of period
|
$ | 7,634 | $ | 8,203 | ||||||
|
Net periodic benefit cost
|
160 | 234 | ||||||||
|
Plan contributions
|
(122 | ) | (152 | ) | ||||||
|
Amortization of net loss
|
(67 | ) | (68 | ) | ||||||
|
Amortization of prior service cost
|
6 | (12 | ) | |||||||
|
Effect of exchange rate changes
|
(18 | ) | (81 | ) | ||||||
|
Balance at end of period
|
$ | 7,593 | $ | 8,124 | ||||||
|
(in thousands of dollars)
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Non current liabilities
|
$ | 7,593 | $ | 8,124 | ||||||
|
(in thousands of dollars)
|
||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||
|
Amortization of net actuarial loss net of tax benefit
|
$ | 50 | $ | 49 | ||||
|
Amortization of prior service cost net of tax benefit
|
(4 | ) | 9 | |||||
| $ | 46 | $ | 58 | |||||
|
Level 1*
(Quoted prices in active
markets)
|
Level 2**
(Significant observable inputs)
|
Level 3***
(Unobservable inputs)
|
||||||||||||
|
Mutual Funds
|
||||||||||||||
|
Standard Life Pension Global Absolute Returns Strategies Fund
|
5,378 | - | - | |||||||||||
|
Standard Life UK Indexed Linked Fund
|
1,591 | - | - | |||||||||||
|
Standard Life Long Corporate Bond Fund
|
1,343 | - | - | |||||||||||
|
CF Ruffer Absolute Return Fund
|
5,799 | - | - | |||||||||||
|
U.S. Equity Funds
|
1,097 | - | - | |||||||||||
|
U.S. Fixed Income Funds
|
840 | - | - | |||||||||||
|
Other Types of Investments
|
||||||||||||||
|
Cash
|
178 | - | - | |||||||||||
|
Total
|
16,226 | - | - | |||||||||||
|
*
|
Level 1 investments represent mutual funds for which a quoted market price is available on an active market. These investments will primarily hold stocks or bonds, or a combination of stocks and bonds.
|
|
**
|
The Company currently does not have any Level 2 pension plan financial assets.
|
|
***
|
The Company currently does not have any Level 3 pension plan financial assets.
|
|
(in thousands
of dollars)
|
||||||
|
2012
|
$ | 406 | ||||
|
2013
|
371 | |||||
|
2014
|
513 | |||||
|
2015
|
658 | |||||
|
2016
|
726 | |||||
| 2017 - 2021 | 3,910 | |||||
|
(in thousands of dollars)
|
||||||||||
|
December 31,
2011
|
September 30,
2011
|
|||||||||
|
Raw materials
|
$ | 3,106 | $ | 1,281 | ||||||
|
Work-in-process
|
65 | 99 | ||||||||
|
Finished goods
|
4,623 | 6,098 | ||||||||
| $ | 7,794 | $ | 7,748 | |||||||
|
(in thousands of dollars)
|
||||||||||
|
December 31,
2011
|
September 30,
2011
|
|||||||||
|
Accrued compensation and related costs
|
$ | 1,017 | $ | 1,090 | ||||||
|
Warranty reserves
|
87 | 89 | ||||||||
|
Other accrued expenses
|
482 | 927 | ||||||||
| $ | 1,586 | $ | 2,106 | |||||||
|
(in thousands of dollars)
|
||||||||||
|
Three Months ended
|
||||||||||
|
December 31,
2011
|
January 1,
2011
|
|||||||||
|
Warranty reserves at beginning of period
|
$ | 89 | $ | 96 | ||||||
|
Decrease in beginning balance for warranty obligations settled during the period
|
(2 | ) | - | |||||||
|
Foreign currency translation adjustment
|
(1 | ) | (1 | ) | ||||||
|
Net increase in warranty reserves for products sold during the period
|
1 | 24 | ||||||||
|
Warranty reserves at end of period
|
$ | 87 | $ | 119 | ||||||
|
2012
|
$ | 29 | ||||
|
2013
|
41 | |||||
|
2014
|
1,744 | |||||
|
2015
|
27 | |||||
| $ | 1,841 | |||||
|
(i)
|
if the financial condition of any of the Company's customers deteriorates as a result of further business declines, the Company may be required to increase its estimated allowance for bad debts;
|
|
(ii)
|
if actual future demand is less than previously projected, inventory write-downs may be required; or
|
|
(iii)
|
significant negative industry or economic trends that adversely affect our future revenues and profits, or a reduction of our market capitalization relative to net book value, among other factors, may change the estimated future cash flows or other factors that we use to determine whether or not goodwill has been impaired and lead us to conclude that an impairment charge is required.
|
|
Three months ended
|
Favorable (unfavorable) % change due to:
|
|||||||||||||||||||
|
December 31,
2011
|
January 1,
2011
|
Total
|
Currency
|
Volume
|
||||||||||||||||
|
Sales:
|
||||||||||||||||||||
|
Controls - to external customers
|
$ | 8,073 | $ | 6,386 | 26 | - | 26 | |||||||||||||
|
Capacitors - to external customers
|
442 | 497 | (11 | ) | - | (11 | ) | |||||||||||||
|
Capacitors - inter-segment
|
5 | 3 | (56 | ) | (1 | ) | 57 | |||||||||||||
|
Capacitors – total
|
447 | 500 | (11 | ) | - | (11 | ) | |||||||||||||
|
Total sales to external customers
|
8,515 | 6,883 | 24 | - | 24 | |||||||||||||||
|
Gross Profit:
|
||||||||||||||||||||
|
Controls
|
2,836 | 2,145 | 32 | (1 | ) | 33 | ||||||||||||||
|
Capacitors
|
146 | 223 | (34 | ) | 1 | 35 | ||||||||||||||
|
Total
|
2,982 | 2,368 | 26 | (1 | ) | 27 | ||||||||||||||
|
Selling research and administrative expenses:
|
||||||||||||||||||||
|
Controls
|
2,540 | 2,142 | 19 | - | 19 | |||||||||||||||
|
Capacitors
|
174 | 166 | 5 | - | 5 | |||||||||||||||
|
Unallocated corporate expense
|
16 | 27 | (41 | ) | - | (41 | ) | |||||||||||||
|
Total
|
2,730 | 2,335 | 17 | - | 17 | |||||||||||||||
|
Operating income:
|
||||||||||||||||||||
|
Controls
|
296 | 3 | 9,767 | (1,003 | ) | 10,770 | ||||||||||||||
|
Capacitors
|
(28 | ) | 57 | (149 | ) | 4 | (153 | ) | ||||||||||||
|
Unallocated corporate expense
|
(16 | ) | (27 | ) | (41 | ) | - | (41 | ) | |||||||||||
|
Total
|
252 | 33 | 664 | (84 | ) | 748 | ||||||||||||||
|
Other income and expense
|
121 | (27 | ) | 546 | 550 | (4 | ) | |||||||||||||
|
Income before income tax
|
373 | 6 | 6,117 | 2,010 | 4,107 | |||||||||||||||
|
Income tax
|
(89 | ) | (1 | ) | (8,800 | ) | 2,863 | 5,937 | ||||||||||||
|
Net income
|
$ | 284 | $ | 5 | 5,580 | 1,840 | 3,740 | |||||||||||||
|
(in thousands of dollars)
|
||||||||||
|
Expected maturity or
transaction date
|
||||||||||
|
Fiscal 2012
|
Fair Value
|
|||||||||
|
On balance sheet financial instruments:
|
||||||||||
|
In $ U.S. Functional Currency
|
||||||||||
|
Accounts receivable in British Pounds
|
941 | 941 | ||||||||
|
Accounts receivable in Euros
|
2,816 | 2,816 | ||||||||
|
Accounts payable in British Pounds
|
438 | 438 | ||||||||
|
Accounts payable in Euros
|
2,285 | 2,285 | ||||||||
|
Anticipated Transactions
|
||||||||||
|
In $ U.S. Functional Currency
|
||||||||||
|
Firmly committed sales contracts
|
||||||||||
|
In British Pounds
|
710 | 710 | ||||||||
|
In Euros
|
3,000 | 3,000 | ||||||||
|
SEVCON, INC.
|
|
|
Date: February 10, 2012
|
By: /s/ Paul N. Farquhar
|
|
|
|
|
Paul N. Farquhar
|
|
|
Chief Financial Officer (Principal Financial Officer)
|
|
Exhibit
|
Description
|
|
|
|
|
3.1
|
Restated Certificate of Incorporation of the registrant (incorporated by reference to Exhibit (3) (a) to the 2011 Annual Report on Form 10-K).
|
|
3.2
|
Amended and Restated By-laws of the registrant (incorporated by reference to Exhibit (3) (b) to the 2011 Annual Report on Form 10-K).
|
|
31.1
|
Certification of Principal Executive Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
31.2
|
Certification of Principal Financial Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
32.1
101
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
The following materials formatted in eXtensible Business Reporting Language (XBRL): (i) Consolidated Income Statements , (ii) Consolidated Balance Sheets, (iii) Consolidated Statements of Cash Flows and (iv) Notes to Consolidated Financial Statements. These materials are furnished and not “filed” herewith.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|